Skip to main navigation Skip to search Skip to main content

HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE

  • L. S. Freedman
  • , W. G. Jones
  • , M. J. Peckham
  • , E. S. Newlands
  • , M. C. Parkinson
  • , R. T.D. Oliver
  • , G. Read
  • , C. J. Williams
  • Medical Research Council
  • Leeds Teaching Hospitals NHS Trust
  • Royal Marsden NHS Foundation Trust
  • Imperial College Healthcare NHS Trust
  • Providence Health Care Canada
  • Barts Health NHS Trust
  • The Christie NHS Foundation Trust
  • University Hospital Southampton NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

336 Scopus citations

Abstract

259 patients with stage I non-seminomatous germ-cell testicular teratoma who were treated by orchidectomy alone and monitored at one often centres in the United Kingdom were followed for a median of 30 months. 62 of the 70 relapses occurred in the first 18 months after orchidectomy. The 2-year relapse-free rate was 74%, falling to 68% at 4 years. Histological sections from 233 of the orchidectomy specimens were reviewed centrally. Four features independently predicted relapses: invasion of testicular veins, invasion of testicular lymphatics, absence of yolk-sac elements, and presence of undifferentiated tumour. An index, based on the number of these features observed, identified a high-risk subgroup of 55 patients who had a 42% relapse-free rate at 2 years.

Original languageEnglish
Pages (from-to)294-298
Number of pages5
JournalThe Lancet
Volume330
Issue number8554
DOIs
StatePublished - 8 Aug 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE'. Together they form a unique fingerprint.

Cite this